Ronald M. Schwartz, MD, of the Neurological Research Center at Hattiesburg Clinic, MS recently gave an interview about the DaTscan test, an imaging agent that was approved by the FDA. The DaTscan is a nuclear medicine test that enables doctors to differentiate between Parkinsonian syndromes and essential tremors.
This video is posted on our website – Essential Tremor in the News.
DaTscan is the first FDA-approved diagnostic imaging agent to help physicians evaluate neurodegenerative movement disorders, such as idiopathic (of unknown cause) Parkinson’s disease (PD). This agent may be used in conjunction with other diagnostic evaluations to help differentiate essential tremor (an involuntary shaking of the hands, head, and voice) from tremor due to PS. DaTscan cannot differentiate between the different types of PS.